key: cord-0959432-xopn0vhq
authors: Meng, Long; Huang, Jing; Qiu, Feng; Sun, Shusen
title: Roles of the Chinese clinical pharmacist during the COVID‐19 pandemic
date: 2020-06-04
journal: J Am Coll Clin Pharm
DOI: 10.1002/jac5.1274
sha: afac1b87165b4f22e1ddc26bd5761706c4450720
doc_id: 959432
cord_uid: xopn0vhq

nan

system has been established, and the clinical pharmacist has become an essential member of the multi-disciplinary team providing pharmaceutical care to patients. Chinese clinical pharmacists provide education, medication review, adverse drug reaction (ADR) monitoring services for patients, and sometimes make medication and laboratory recommendations or provide medication consultation for other healthcare providers. 2 The respiratory illness due to SARS-CoV-2, termed COVID-19, is now a worldwide pandemic. Chinese clinical pharmacists actively provide a variety of pharmacy services during the coronavirus pandemic, demonstrating the impact of the clinical pharmacist system. 3, 4 In this editorial, we describe the roles of the Chinese clinical pharmacists during the COVID-19 pandemic to share with the international pharmacy community. Table 1 . [6] [7] [8] Clinical pharmacists pay particular attention to the special patient populations-elderly, 9 pregnant, children, and patients with comorbidities. 10, 11 Clinical pharmacists also closely monitor drugs/drug classes with more safety concerns, such as lopinavir/ritonavir, 12 ribavirin, 13 interferon, 14 tocilizumab, 15 glucocorticoids, 16 and immunomodulatory drugs. 17 

An evaluation of clinical pharmacist service on a neurology care unit

The impact of the clinical pharmacistled interventions in China: A systematic review and Meta-Analysis

Providing pharmacy services during the coronavirus pandemic

Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China

Diagnosis and Treatment Guidelines for the New Coronavirus Infected Pneumonia (seventh update). China

Discussion on clinical pharmaceutical service model in prevention and treatment of corona virus disease 2019

Comprehensive Pharmaceutical Care for Novel Coronavirus Pneumonia

Pharmaceutical Care Strategies of Clinical Pharmacists During the Prevention and Control of the Coronavirus Disease

Pharmaceutical Care of Elderly Patients with the Coronavirus Disease

Study on the strategy and application of anticoagulant pharmaceutical care during Coronavirus Disease

Pharmaceutical Care for Cancer Patients Receiving Antitumor Treatment during the Outbreak of Corona Virus Disease

Pharmacological recommendations on the off-label use of Lopinavir/ritonavir for treatment of coronavirus disease 2019

Application, evaluation and pharmaceutical care of ribavirin in the treatment of viral diseases

Rational Administration and Pharmaceutical Care of Interferon Alpha Nebulization Therapy in Corona Virus Disease

Pharmacological recommendations on tocilizumab for the treatment of COVID-19

Pharmaceutical Care of Glucocorticoid in Corona Virus Disease

Rational Use and Pharmaceutical Care of ThymosinImmunomodulators for Novel Coronavirus Pneumonia. Herald of Medicine

Risk signals mining of ribavirin and interferon-alpha based on the US FDA Adverse Event Reporting System database

Detection and Analysis of the Safety Signals of Lopinavir/Ritonavir Based on FDA Adverse Event Database

Practice and discussion of outpatient pharmaceutical care based on medical network model during 2019 novel coronavirus disease (COVID-19)

Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19)

Fighting against COVID-19: Innovative strategies for clinical pharmacists

Construction of Pharmaceutical Care System for Public Health Emergencies Based on the Pharmaceutical Administration in Wuhan Fangcang Hospitals